Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Fortress Biotech, Inc. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - Fortress Biotech, Inc. | v403230_ex31-1.htm |
| EX-23.2 - EXHIBIT 23.2 - Fortress Biotech, Inc. | v403230_ex23-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Fortress Biotech, Inc. | v403230_ex32-2.htm |
| EX-23.1 - EXHIBIT 23.1 - Fortress Biotech, Inc. | v403230_ex23-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Fortress Biotech, Inc. | v403230_ex32-1.htm |
| 10-K - FORM 10-K - Fortress Biotech, Inc. | v403230_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - Fortress Biotech, Inc. | v403230_ex31-2.htm |
EXHIBIT 21.1
SUBSIDIARIES OF CORONADO BIOSCIENCES, INC.
Subsidiaries of Coronado Biosciences, Inc. at December 31, 2014:
| • | Altamira Bio Inc., formerly TSO Development Corporation, Inc. |
| • | CB Pharma Acquisition Corp. |
| • | CB Securities Corporation |
| • | Coronado SO Co., Inc. |
| • | Cyprium, Inc. |
| • | Innmune Limited |
| • | Journey Medical Corporation |
Additional subsidiaries of Coronado Biosciences, Inc. formed after December 31, 2014:
| • | Avenue Therapeutics, Inc. |
| • | Checkpoint Therapeutics, Inc. |